CINEPAXADIL

Details

Stereochemistry	RACEMIC
Molecular Formula	C29H36N2O9
Molecular Weight	556.6041
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	1
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

COC1=CC(\C=C\C(=O)N2CCN(CC(O)COC3=CC=C(C(C)=O)C4=C3OCCO4)CC2)=CC(OC)=C1OC

InChI

InChIKey=SYFDPNLESAYNCB-VMPITWQZSA-N

InChI=1S/C29H36N2O9/c1-19(32)22-6-7-23(29-27(22)38-13-14-39-29)40-18-21(33)17-30-9-11-31(12-10-30)26(34)8-5-20-15-24(35-2)28(37-4)25(16-20)36-3/h5-8,15-16,21,33H,9-14,17-18H2,1-4H3/b8-5+

HIDE SMILES / InChI

Molecular Formula	C29H36N2O9
Molecular Weight	556.6041
Charge	0
Count

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	1
Optical Activity	( + / - )

Description
Sources: https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=19781026&CC=DE&NR=2816785A1&KC=A1 | https://www.ncbi.nlm.nih.gov/pubmed/11087578

Cinepaxadil is cinnamoyl-piperazine derivative developed by Delalande SA for treatment cardiovascular system disorders. Cinepaxadil decrease dogs cardiac activity after i.v. administration.

Originator

Approval Year

PubMed

Title	Date	PubMed

Patents

Sample Use Guides

In Vivo Use Guide

2.5 mg/kg i.v. in dogs

Route of Administration: Intravenous

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:24:05 GMT 2023` Edited by `admin` on `Fri Dec 15 16:24:05 GMT 2023`
Record UNII	E052L8N506
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CINEPAXADIL

Official Name

English

cinepaxadil [INN]

Common Name

English

.ALPHA.-(((8-ACETYL-1,4-BENZODIOXAN-5-YL)OXY)METHYL)-4-(3,4,5-TRIMETHOXYCINNAMOYL)-1-PIPERAZINEETHANOL

Systematic Name

English

Classification Tree Code System Code

NCI_THESAURUS

C29707